Form 4: OrbiMed Advisors LLC Reduces Stake in NeuroPace Inc (NPCE)

OrbiMed Advisors LLC, a major shareholder of NeuroPace Inc, reports selling a portion of its common stock holdings.

Summary

• OrbiMed Advisors LLC, along with OrbiMed Capital GP VI LLC, filed a Form 4 detailing changes in beneficial ownership of NeuroPace Inc (NPCE) stock.
• On May 14, 2025, OrbiMed Advisors sold 134,136 shares of common stock at $15.83 per share and 34,000 shares at $15.94 per share.
• Following these transactions, OrbiMed Advisors indirectly holds 3,238,199 shares of NeuroPace Inc through OrbiMed Private Investments VI, LP (OPI VI).
• OrbiMed Capital GP VI LLC is the general partner of OPI VI, and OrbiMed Advisors LLC is the managing member of GP VI, granting them voting and investment power over the shares held by OPI VI.
• Both OrbiMed Advisors and GP VI disclaim beneficial ownership of the securities, except to the extent of their pecuniary interest.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock transactions. The sale itself could be interpreted as slightly negative, but without further context, it's difficult to assess the overall impact.

Negatives

• OrbiMed Advisors LLC reduced its stake in NeuroPace Inc, which could be perceived negatively by some investors.

Risks

• The sale of shares by a major shareholder like OrbiMed Advisors could create short-term price volatility in NeuroPace Inc's stock.

Management Comments

• Carl L. Gordon, Member of OrbiMed Advisors LLC and OrbiMed Capital GP VI LLC, signed the report.
• OrbiMed Advisors exercises its investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI VI.

Industry Context

This filing is a routine disclosure of stock transactions by a major shareholder, which is common in the investment industry. Monitoring such filings helps investors understand the sentiment and actions of significant stakeholders.

Comparison to Industry Standards

• Form 4 filings are standard practice for reporting changes in beneficial ownership as per SEC regulations.
• Similar filings are made by other investment firms like Viking Global Investors, Baker Bros. Advisors, and RA Capital Management when they adjust their holdings in publicly traded companies.

Stakeholder Impact

• Shareholders may react to the news of OrbiMed's stock sale, potentially leading to short-term price fluctuations.
• The impact on other stakeholders (employees, customers, etc.) is likely minimal unless this sale signals a larger strategic shift.

Key Dates

Keywords

NeuroPace, OrbiMed Advisors, stock sale, beneficial ownership, NPCE, Form 4